ArticleCancer biomarkers : section A of Disease markers2020

LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.

Ji-Feng Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.